Safety and efficacy of loteprednol etabonate ophthalmic ointment 0.5% for the treatment of inflammation and pain following cataract surgery
Timothy L Comstock1 Michael R Paterno1 Angele Singh1 Tara Erb1 Elizabeth Davis21Bausch and Lomb Inc., Rochester, NY, USA; 2Minnesota Eye Consultants, Bloomington, MN, USABackground: To compare the safety and efficacy of loteprednol etabonate ophthalmic ointment 0.5% (LE ointment), a new topical oint...
Main Authors: | Timothy L Comstock, Michael R Paterno, Angele Singh, et al |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-02-01
|
Series: | Clinical Ophthalmology |
Online Access: | http://www.dovepress.com/safety-and-efficacy-of-loteprednol-etabonate-ophthalmic-ointment-05-fo-a6275 |
Similar Items
-
An update on the surgical management of pterygium and the role of loteprednol etabonate ointment
by: Sheppard JD, et al.
Published: (2014-06-01) -
Advances in Corticosteroid Therapy for Ocular Inflammation: Loteprednol Etabonate
by: Timothy L. Comstock, et al.
Published: (2012-01-01) -
Loteprednol etabonate gel 0.5% for postoperative pain and inflammation after cataract surgery: results of a multicenter trial
by: Fong R, et al.
Published: (2012-07-01) -
A retrospective analysis of the use of loteprednol etabonate ophthalmic suspension 0.5% following canaloplasty
by: Khaimi MA
Published: (2018-02-01) -
Dose uniformity of loteprednol etabonate ophthalmic gel (0.5%) compared with branded and generic prednisolone acetate ophthalmic suspension (1%)
by: Marlowe ZT, et al.
Published: (2013-12-01)